Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
Clinical trial NCT06128863 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06128863
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-17
- Primary completion
- 2025-04-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.